default author photo

Hanrui Jiang

Wuhan Institute of Technology

China

SCHOLARLY PAPERS

1

DOWNLOADS

48

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Discovery of Novel Imidazo[1,2-B]Pyridazine Derivatives as Potent Covalent Inhibitors of Cdk12/13

Number of pages: 40 Posted: 23 Dec 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Wuhan Institute of Technology, Shenyang Pharmaceutical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Wuhan Institute of Technology, Nanjing University of Chinese Medicine (NJUCM) and Chinese Academy of Sciences (CAS) - State Key Laboratory of Drug Research
Downloads 48 (1,086,013)

Abstract:

Loading...

Triple-negative breast cancer, CDK12/13 covalent inhibitors, Cys-1039, THZ531